Company reports 21% sequential growth in domestic handpiece unit sales
IRVINE, Calif., May 15 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation (Pink Sheets: CGCP), a leading developer of surgical products and accessories used in angina-relieving procedures, today reported financial results for its first quarter ended March 31, 2008.
Sales in the first quarter of 2008 totaled $2,982,000, a 12% decrease from the prior year first quarter sales of $3,370,000. During the first quarter of 2008, the Company sold three lasers and 540 handpiece units as compared to five lasers and 656 handpieces during the first quarter of 2007. The lower revenue in the current year quarter is primarily attributable to a $260,000, or 11%, decline in disposable handpiece revenue, and a $104,000, or 14%, decrease in capital sales as compared with the prior year quarter.
"We are very encouraged by the 21% sequential growth in domestic sales of disposable units from the fourth quarter of 2007. We believe it is an indication of the impact our new sales team is having in establishing themselves and increasing the usage of our technology," commented Richard Lanigan, Cardiogenesis' President. Lanigan also noted "The Company continues to balance its investment in sales and marketing with its finances. A combination of an increased ending cash balance of $2,917,000, and the fact that we were essentially break even from operations in the first quarter, means that we can continue to invest in "feet on the street" to maintain our sales momentum."
Cardiogenesis reported a first quarter 2008 operating loss of $37,000 as compared with operating income of $465,000 in the prior year quarter. The net loss for the quarter was $36,000, or $0.00 per basic and diluted share, as compared with net income of $327,000, or $0.01 per basic and diluted share, in the 2007 first quarter.
Gross margin was 82% of sales for the first quarter of 2008 as compared
with an 81% gross mar
'/>"/>
| SOURCE Cardiogenesis Corporation Copyright©2008 PR Newswire. All rights reserved |